CompletedNot Applicable

Use of an External Erectile Device in Transgender Man Following Phalloplasty

United States15 participantsStarted 2019-07-01

Plain-language summary

The purpose of this study is to test whether an external erectile prosthesis (The Elator™) is a feasible alternative to internal erectile prostheses for transgender men who have undergone a phalloplasty with glansplasty and wish to use their neophallus for sexual penetration. The Elator™ was initially developed for men experiencing erectile dysfunction after prostate cancer. The device consists of two silicone rings connected by a pair of plastic coated rigid metal rods. One ring goes at the base of the penis. The other ring is connected to the rods. This ring is placed behind the glans, and then the rods are connected to the base ring to stretch and provide rigidity to the phallus.

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary study subject must have had a phalloplasty with glansplasty a minimum of 1 year before enrollment and must have protective sensation to the tip of the phallus * Primary study subject must be in a relationship in which they are having, or would like to have, penetrative sex with their partner. Partner must also be interested in having penetrative sex with primary subject. * Both primary study subject and partner must have (individual) e-mail addresses and access to the Internet to complete surveys * Primary study subject must be willing to be contacted by postal mail, in order to receive the device * Both subjects must be willing to receive e-mails Exclusion Criteria: * Either subject or partner does not speak English * Primary subject has an internal erectile prosthesis.

What they're measuring

Change in Quality of Sexual Experience Scale

Timeframe: Baseline and at study completion (~1.5 months)

Change in Relationship Satisfaction Subscale

Timeframe: Baseline and at study completion (~1.5 months)

Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS)

Timeframe: The intervention period of 4 weeks, assessed at study completion

Trial details

NCT IDNCT03823014

SponsorBoston Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-01

View on ClinicalTrials.gov More Transsexualism trials

Plain-language summary

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Quality of Sexual Experience Scale

Timeframe: Baseline and at study completion (~1.5 months)

Change in Relationship Satisfaction Subscale

Timeframe: Baseline and at study completion (~1.5 months)

Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS)

Timeframe: The intervention period of 4 weeks, assessed at study completion